Skip to main content

Home
Specialties
Resources
CME

Search Videos and More

search

Channel Categories

Breast Cancer (18)
Cancer Screening and Survivorship (5)
Cell Therapy (20)
Clinical Trials (6)
COVID-19 (7)
Gastrointestinal Cancer (7)
Genitourinary Cancer (6)
Gynecologic Oncology (7)
Head and Neck Cancer (8)
Hematologic Oncology (26)
Immunotherapy (26)
Neuro-Oncology (6)
Pediatric Hematology/Oncology (8)
Primary Care (6)
Radiation Oncology (8)
Skin Cancer (7)
Thoracic Cancer (8)
Young Adult Malignancies (2)

Types

News (122)

Showing 1 - 12 of 122 results

Previous| 1 | 2 | 3 ...11 |Next

Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo

Governor Hochul Celebrates Opening of New York’s First Cell and Gene Therapy Hub at Roswell Park Comprehensive Cancer Center In Buffalo

Can NST-628 Fill the Treatment Void For Advanced Tumors with RAS or RAF Mutations?

Can NST-628 Fill the Treatment Void For Advanced Tumors with RAS or RAF Mutations?

Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting

Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting

$Clinical Trial Utilizes Novel CAR Target for Relapsed/Refractory Multiple Myeloma$ News

Clinical Trial Utilizes Novel CAR Target for Relapsed/Refractory Multiple Myeloma

Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

Inherited Changes in BRCA Genes Linked to Increased Risk of Multiple Myeloma

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Congressman Kennedy Announces Over $7.7 Million for State-of-the-Art Biobank at Roswell Park

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

Clinical Trial Evaluates Promising Immunotherapy Combination For Metastatic Triple Negative Breast Cancer

Clinical Trial Evaluates Promising Immunotherapy Combination For Metastatic Triple Negative Breast Cancer

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.

FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.

Next Generation Armored Car T-Cell Therapy Trial Now Open

Next Generation Armored Car T-Cell Therapy Trial Now Open

Roswell Park Ranked by Forbes Among America’s Best Employers for Women 2024

Roswell Park Ranked by Forbes Among America’s Best Employers for Women 2024

Showing 1 - 12 of 122 results

Previous| 1 | 2 | 3 ...11 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer